Biocompatibility of high-flux membranes

D Putz1, U Barnas, A Luger

  • 12nd Department of Medicine, University of Vienna, Austria.

Insights

Modern high-flux dialyzers show superior biocompatibility compared to cuprophane membranes. These synthetic and semisynthetic membranes do not stimulate immune responses, unlike older cuprophane types.

Area of Science:

  • Nephrology
  • Immunology
  • Biomaterials Science

Background:

  • Standard dialysis membranes like cuprophane are known to activate the immune system, leading to the secretion of inflammatory cytokines.
  • This immune stimulation indicates poor biocompatibility of cuprophane membranes.

Purpose of the Study:

  • To investigate the immunogenic properties of three modern high-flux dialysis membranes.
  • To compare the biocompatibility of novel membranes with conventional cuprophane.

Main Methods:

  • A study involving seven patients undergoing hemodiafiltration.
  • Serial measurements of immune markers including interleukin-1 beta, tumor necrosis factor (TNF), soluble IL-2 receptor, soluble CD4, soluble CD8, interferon gamma, and neopterin.
  • Use of polysulfone, polymethylmetacrylate, and cellulose triacetate dialyzers.

Main Results:

  • None of the modern high-flux dialyzers stimulated the production of key inflammatory factors (IL-1 beta, TNF, IL-2r).
  • Significant decreases in neopterin and soluble CD4 levels were observed.
  • Interferon gamma and soluble CD8 levels did not change significantly.

Conclusions:

  • Modern high-flux dialyzers demonstrate non-immunogenic properties.
  • Synthetic and semisynthetic membranes exhibit superior biocompatibility over conventional cuprophane membranes in dialysis.

Related Concept Videos